- Home
- GILD vs ENB Comparison
GILD vs ENB Comparison
Compare GILD & ENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- ENB
- Stock Information
- Founded
- GILD 1987
- ENB 1949
- Country
- GILD United States
- ENB Canada
- Employees
- GILD N/A
- ENB N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- ENB Natural Gas Distribution
- Sector
- GILD Health Care
- ENB Energy
- Exchange
- GILD Nasdaq
- ENB Nasdaq
- Market Cap
- GILD 113.0B
- ENB 92.1B
- IPO Year
- GILD 1992
- ENB N/A
- Fundamental
- Price
- GILD $92.98
- ENB $41.16
- Analyst Decision
- GILD Buy
- ENB Buy
- Analyst Count
- GILD 26
- ENB 1
- Target Price
- GILD $96.71
- ENB $63.00
- AVG Volume (30 Days)
- GILD 6.4M
- ENB 4.7M
- Earning Date
- GILD 02-11-2025
- ENB 02-07-2025
- Dividend Yield
- GILD 3.38%
- ENB 6.57%
- EPS Growth
- GILD N/A
- ENB 95.58
- EPS
- GILD 0.10
- ENB 2.17
- Revenue
- GILD $28,299,000,000.00
- ENB $35,940,634,354.00
- Revenue This Year
- GILD $6.54
- ENB $5.15
- Revenue Next Year
- GILD N/A
- ENB N/A
- P/E Ratio
- GILD $937.76
- ENB $18.76
- Revenue Growth
- GILD 3.31
- ENB 6.07
- 52 Week Low
- GILD $62.07
- ENB $32.85
- 52 Week High
- GILD $98.90
- ENB $44.14
- Technical
- Relative Strength Index (RSI)
- GILD 52.30
- ENB 33.03
- Support Level
- GILD $90.27
- ENB $42.13
- Resistance Level
- GILD $93.59
- ENB $42.74
- Average True Range (ATR)
- GILD 2.12
- ENB 0.58
- MACD
- GILD -0.21
- ENB -0.32
- Stochastic Oscillator
- GILD 50.91
- ENB 6.61
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About ENB Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the us and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. The firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.